Global Cisplatin Injection Market Insights, Forecast to 2028

Publisher Name :
Date: 28-Apr-2022
No. of pages: 106
Inquire Before Buying

Cisplatin Injection market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cisplatin Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- 50ml

- 100ml

- 200ml

Segment by Application

- NSCLC

- Ovarian Cancer

- Testicular Cancer

- ??

By Company

- Nanjing Pharmaceutical Factory

- Lingnan Pharmacy

- Hansoh Pharma

- Bievalley

- Yunnan Phytopharmaceutical

- Qilu Pharmaceutical

- Luoxin

- Jinzhou Jiutai Pharmaceutical

- Fresenius Kabi

- Teva

- Cipla

- Hospira(Pfizer)

- Taj Pharmaceuticals

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Cisplatin Injection Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Cisplatin Injection Product Introduction
1.2 Market by Type
1.2.1 Global Cisplatin Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 50ml
1.2.3 100ml
1.2.4 200ml
1.3 Market by Application
1.3.1 Global Cisplatin Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 NSCLC
1.3.3 Ovarian Cancer
1.3.4 Testicular Cancer
1.3.5 ??
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cisplatin Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Cisplatin Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Cisplatin Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cisplatin Injection Sales by Region
2.4.1 Global Cisplatin Injection Sales by Region (2017-2022)
2.4.2 Global Sales Cisplatin Injection by Region (2023-2028)
2.5 Global Cisplatin Injection Revenue by Region
2.5.1 Global Cisplatin Injection Revenue by Region (2017-2022)
2.5.2 Global Cisplatin Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cisplatin Injection Sales by Manufacturers
3.1.1 Global Top Cisplatin Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Cisplatin Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cisplatin Injection in 2021
3.2 Global Cisplatin Injection Revenue by Manufacturers
3.2.1 Global Cisplatin Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Cisplatin Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cisplatin Injection Revenue in 2021
3.3 Global Cisplatin Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cisplatin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cisplatin Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cisplatin Injection Sales by Type
4.1.1 Global Cisplatin Injection Historical Sales by Type (2017-2022)
4.1.2 Global Cisplatin Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Cisplatin Injection Sales Market Share by Type (2017-2028)
4.2 Global Cisplatin Injection Revenue by Type
4.2.1 Global Cisplatin Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Cisplatin Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cisplatin Injection Revenue Market Share by Type (2017-2028)
4.3 Global Cisplatin Injection Price by Type
4.3.1 Global Cisplatin Injection Price by Type (2017-2022)
4.3.2 Global Cisplatin Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cisplatin Injection Sales by Application
5.1.1 Global Cisplatin Injection Historical Sales by Application (2017-2022)
5.1.2 Global Cisplatin Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Cisplatin Injection Sales Market Share by Application (2017-2028)
5.2 Global Cisplatin Injection Revenue by Application
5.2.1 Global Cisplatin Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Cisplatin Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cisplatin Injection Revenue Market Share by Application (2017-2028)
5.3 Global Cisplatin Injection Price by Application
5.3.1 Global Cisplatin Injection Price by Application (2017-2022)
5.3.2 Global Cisplatin Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cisplatin Injection Market Size by Type
6.1.1 North America Cisplatin Injection Sales by Type (2017-2028)
6.1.2 North America Cisplatin Injection Revenue by Type (2017-2028)
6.2 North America Cisplatin Injection Market Size by Application
6.2.1 North America Cisplatin Injection Sales by Application (2017-2028)
6.2.2 North America Cisplatin Injection Revenue by Application (2017-2028)
6.3 North America Cisplatin Injection Market Size by Country
6.3.1 North America Cisplatin Injection Sales by Country (2017-2028)
6.3.2 North America Cisplatin Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Cisplatin Injection Market Size by Type
7.1.1 Europe Cisplatin Injection Sales by Type (2017-2028)
7.1.2 Europe Cisplatin Injection Revenue by Type (2017-2028)
7.2 Europe Cisplatin Injection Market Size by Application
7.2.1 Europe Cisplatin Injection Sales by Application (2017-2028)
7.2.2 Europe Cisplatin Injection Revenue by Application (2017-2028)
7.3 Europe Cisplatin Injection Market Size by Country
7.3.1 Europe Cisplatin Injection Sales by Country (2017-2028)
7.3.2 Europe Cisplatin Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cisplatin Injection Market Size by Type
8.1.1 Asia Pacific Cisplatin Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Cisplatin Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Cisplatin Injection Market Size by Application
8.2.1 Asia Pacific Cisplatin Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Cisplatin Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Cisplatin Injection Market Size by Region
8.3.1 Asia Pacific Cisplatin Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Cisplatin Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Cisplatin Injection Market Size by Type
9.1.1 Latin America Cisplatin Injection Sales by Type (2017-2028)
9.1.2 Latin America Cisplatin Injection Revenue by Type (2017-2028)
9.2 Latin America Cisplatin Injection Market Size by Application
9.2.1 Latin America Cisplatin Injection Sales by Application (2017-2028)
9.2.2 Latin America Cisplatin Injection Revenue by Application (2017-2028)
9.3 Latin America Cisplatin Injection Market Size by Country
9.3.1 Latin America Cisplatin Injection Sales by Country (2017-2028)
9.3.2 Latin America Cisplatin Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cisplatin Injection Market Size by Type
10.1.1 Middle East and Africa Cisplatin Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cisplatin Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Cisplatin Injection Market Size by Application
10.2.1 Middle East and Africa Cisplatin Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cisplatin Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Cisplatin Injection Market Size by Country
10.3.1 Middle East and Africa Cisplatin Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cisplatin Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Nanjing Pharmaceutical Factory
11.1.1 Nanjing Pharmaceutical Factory Corporation Information
11.1.2 Nanjing Pharmaceutical Factory Overview
11.1.3 Nanjing Pharmaceutical Factory Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Nanjing Pharmaceutical Factory Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Nanjing Pharmaceutical Factory Recent Developments
11.2 Lingnan Pharmacy
11.2.1 Lingnan Pharmacy Corporation Information
11.2.2 Lingnan Pharmacy Overview
11.2.3 Lingnan Pharmacy Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Lingnan Pharmacy Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lingnan Pharmacy Recent Developments
11.3 Hansoh Pharma
11.3.1 Hansoh Pharma Corporation Information
11.3.2 Hansoh Pharma Overview
11.3.3 Hansoh Pharma Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Hansoh Pharma Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hansoh Pharma Recent Developments
11.4 Bievalley
11.4.1 Bievalley Corporation Information
11.4.2 Bievalley Overview
11.4.3 Bievalley Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bievalley Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bievalley Recent Developments
11.5 Yunnan Phytopharmaceutical
11.5.1 Yunnan Phytopharmaceutical Corporation Information
11.5.2 Yunnan Phytopharmaceutical Overview
11.5.3 Yunnan Phytopharmaceutical Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Yunnan Phytopharmaceutical Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Yunnan Phytopharmaceutical Recent Developments
11.6 Qilu Pharmaceutical
11.6.1 Qilu Pharmaceutical Corporation Information
11.6.2 Qilu Pharmaceutical Overview
11.6.3 Qilu Pharmaceutical Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Qilu Pharmaceutical Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Qilu Pharmaceutical Recent Developments
11.7 Luoxin
11.7.1 Luoxin Corporation Information
11.7.2 Luoxin Overview
11.7.3 Luoxin Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Luoxin Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Luoxin Recent Developments
11.8 Jinzhou Jiutai Pharmaceutical
11.8.1 Jinzhou Jiutai Pharmaceutical Corporation Information
11.8.2 Jinzhou Jiutai Pharmaceutical Overview
11.8.3 Jinzhou Jiutai Pharmaceutical Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Jinzhou Jiutai Pharmaceutical Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Jinzhou Jiutai Pharmaceutical Recent Developments
11.9 Fresenius Kabi
11.9.1 Fresenius Kabi Corporation Information
11.9.2 Fresenius Kabi Overview
11.9.3 Fresenius Kabi Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Fresenius Kabi Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Fresenius Kabi Recent Developments
11.10 Teva
11.10.1 Teva Corporation Information
11.10.2 Teva Overview
11.10.3 Teva Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Recent Developments
11.11 Cipla
11.11.1 Cipla Corporation Information
11.11.2 Cipla Overview
11.11.3 Cipla Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Cipla Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Cipla Recent Developments
11.12 Hospira(Pfizer)
11.12.1 Hospira(Pfizer) Corporation Information
11.12.2 Hospira(Pfizer) Overview
11.12.3 Hospira(Pfizer) Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Hospira(Pfizer) Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hospira(Pfizer) Recent Developments
11.13 Taj Pharmaceuticals
11.13.1 Taj Pharmaceuticals Corporation Information
11.13.2 Taj Pharmaceuticals Overview
11.13.3 Taj Pharmaceuticals Cisplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Taj Pharmaceuticals Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Taj Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cisplatin Injection Industry Chain Analysis
12.2 Cisplatin Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cisplatin Injection Production Mode & Process
12.4 Cisplatin Injection Sales and Marketing
12.4.1 Cisplatin Injection Sales Channels
12.4.2 Cisplatin Injection Distributors
12.5 Cisplatin Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cisplatin Injection Industry Trends
13.2 Cisplatin Injection Market Drivers
13.3 Cisplatin Injection Market Challenges
13.4 Cisplatin Injection Market Restraints
14 Key Findings in The Global Cisplatin Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Cisplatin Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 50ml
Table 3. Major Manufacturers of 100ml
Table 4. Major Manufacturers of 200ml
Table 5. Global Cisplatin Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Cisplatin Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Cisplatin Injection Sales by Region (2017-2022) & (K Units)
Table 8. Global Cisplatin Injection Sales Market Share by Region (2017-2022)
Table 9. Global Cisplatin Injection Sales by Region (2023-2028) & (K Units)
Table 10. Global Cisplatin Injection Sales Market Share by Region (2023-2028)
Table 11. Global Cisplatin Injection Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Cisplatin Injection Revenue Market Share by Region (2017-2022)
Table 13. Global Cisplatin Injection Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Cisplatin Injection Revenue Market Share by Region (2023-2028)
Table 15. Global Cisplatin Injection Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Cisplatin Injection Sales Share by Manufacturers (2017-2022)
Table 17. Global Cisplatin Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Cisplatin Injection Revenue Share by Manufacturers (2017-2022)
Table 19. Cisplatin Injection Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Cisplatin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Cisplatin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cisplatin Injection as of 2021)
Table 22. Cisplatin Injection Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Cisplatin Injection Product Offered
Table 24. Date of Manufacturers Enter into Cisplatin Injection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cisplatin Injection Sales by Type (2017-2022) & (K Units)
Table 27. Global Cisplatin Injection Sales by Type (2023-2028) & (K Units)
Table 28. Global Cisplatin Injection Sales Share by Type (2017-2022)
Table 29. Global Cisplatin Injection Sales Share by Type (2023-2028)
Table 30. Global Cisplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Cisplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Cisplatin Injection Revenue Share by Type (2017-2022)
Table 33. Global Cisplatin Injection Revenue Share by Type (2023-2028)
Table 34. Cisplatin Injection Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Cisplatin Injection Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Cisplatin Injection Sales by Application (2017-2022) & (K Units)
Table 37. Global Cisplatin Injection Sales by Application (2023-2028) & (K Units)
Table 38. Global Cisplatin Injection Sales Share by Application (2017-2022)
Table 39. Global Cisplatin Injection Sales Share by Application (2023-2028)
Table 40. Global Cisplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Cisplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Cisplatin Injection Revenue Share by Application (2017-2022)
Table 43. Global Cisplatin Injection Revenue Share by Application (2023-2028)
Table 44. Cisplatin Injection Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Cisplatin Injection Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Cisplatin Injection Sales by Type (2017-2022) & (K Units)
Table 47. North America Cisplatin Injection Sales by Type (2023-2028) & (K Units)
Table 48. North America Cisplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Cisplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Cisplatin Injection Sales by Application (2017-2022) & (K Units)
Table 51. North America Cisplatin Injection Sales by Application (2023-2028) & (K Units)
Table 52. North America Cisplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Cisplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Cisplatin Injection Sales by Country (2017-2022) & (K Units)
Table 55. North America Cisplatin Injection Sales by Country (2023-2028) & (K Units)
Table 56. North America Cisplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Cisplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Cisplatin Injection Sales by Type (2017-2022) & (K Units)
Table 59. Europe Cisplatin Injection Sales by Type (2023-2028) & (K Units)
Table 60. Europe Cisplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Cisplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Cisplatin Injection Sales by Application (2017-2022) & (K Units)
Table 63. Europe Cisplatin Injection Sales by Application (2023-2028) & (K Units)
Table 64. Europe Cisplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Cisplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Cisplatin Injection Sales by Country (2017-2022) & (K Units)
Table 67. Europe Cisplatin Injection Sales by Country (2023-2028) & (K Units)
Table 68. Europe Cisplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Cisplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Cisplatin Injection Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Cisplatin Injection Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Cisplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Cisplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Cisplatin Injection Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Cisplatin Injection Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Cisplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Cisplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Cisplatin Injection Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Cisplatin Injection Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Cisplatin Injection Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Cisplatin Injection Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Cisplatin Injection Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Cisplatin Injection Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Cisplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Cisplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Cisplatin Injection Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Cisplatin Injection Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Cisplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Cisplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Cisplatin Injection Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Cisplatin Injection Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Cisplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Cisplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Cisplatin Injection Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Cisplatin Injection Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Cisplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Cisplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Cisplatin Injection Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Cisplatin Injection Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Cisplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Cisplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Cisplatin Injection Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Cisplatin Injection Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Cisplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Cisplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 106. Nanjing Pharmaceutical Factory Corporation Information
Table 107. Nanjing Pharmaceutical Factory Description and Major Businesses
Table 108. Nanjing Pharmaceutical Factory Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Nanjing Pharmaceutical Factory Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Nanjing Pharmaceutical Factory Recent Developments
Table 111. Lingnan Pharmacy Corporation Information
Table 112. Lingnan Pharmacy Description and Major Businesses
Table 113. Lingnan Pharmacy Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Lingnan Pharmacy Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Lingnan Pharmacy Recent Developments
Table 116. Hansoh Pharma Corporation Information
Table 117. Hansoh Pharma Description and Major Businesses
Table 118. Hansoh Pharma Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Hansoh Pharma Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Hansoh Pharma Recent Developments
Table 121. Bievalley Corporation Information
Table 122. Bievalley Description and Major Businesses
Table 123. Bievalley Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Bievalley Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Bievalley Recent Developments
Table 126. Yunnan Phytopharmaceutical Corporation Information
Table 127. Yunnan Phytopharmaceutical Description and Major Businesses
Table 128. Yunnan Phytopharmaceutical Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Yunnan Phytopharmaceutical Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Yunnan Phytopharmaceutical Recent Developments
Table 131. Qilu Pharmaceutical Corporation Information
Table 132. Qilu Pharmaceutical Description and Major Businesses
Table 133. Qilu Pharmaceutical Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Qilu Pharmaceutical Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Qilu Pharmaceutical Recent Developments
Table 136. Luoxin Corporation Information
Table 137. Luoxin Description and Major Businesses
Table 138. Luoxin Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Luoxin Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Luoxin Recent Developments
Table 141. Jinzhou Jiutai Pharmaceutical Corporation Information
Table 142. Jinzhou Jiutai Pharmaceutical Description and Major Businesses
Table 143. Jinzhou Jiutai Pharmaceutical Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Jinzhou Jiutai Pharmaceutical Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Jinzhou Jiutai Pharmaceutical Recent Developments
Table 146. Fresenius Kabi Corporation Information
Table 147. Fresenius Kabi Description and Major Businesses
Table 148. Fresenius Kabi Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Fresenius Kabi Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Fresenius Kabi Recent Developments
Table 151. Teva Corporation Information
Table 152. Teva Description and Major Businesses
Table 153. Teva Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Teva Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Teva Recent Developments
Table 156. Cipla Corporation Information
Table 157. Cipla Description and Major Businesses
Table 158. Cipla Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. Cipla Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Cipla Recent Developments
Table 161. Hospira(Pfizer) Corporation Information
Table 162. Hospira(Pfizer) Description and Major Businesses
Table 163. Hospira(Pfizer) Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. Hospira(Pfizer) Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Hospira(Pfizer) Recent Developments
Table 166. Taj Pharmaceuticals Corporation Information
Table 167. Taj Pharmaceuticals Description and Major Businesses
Table 168. Taj Pharmaceuticals Cisplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 169. Taj Pharmaceuticals Cisplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Taj Pharmaceuticals Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Cisplatin Injection Distributors List
Table 174. Cisplatin Injection Customers List
Table 175. Cisplatin Injection Market Trends
Table 176. Cisplatin Injection Market Drivers
Table 177. Cisplatin Injection Market Challenges
Table 178. Cisplatin Injection Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Cisplatin Injection Product Picture
Figure 3. Global Cisplatin Injection Market Share by Type in 2021 & 2028
Figure 3. 50ml Product Picture
Figure 4. 100ml Product Picture
Figure 5. 200ml Product Picture
Figure 6. Global Cisplatin Injection Market Share by Application in 2021 & 2028
Figure 7. NSCLC
Figure 8. Ovarian Cancer
Figure 9. Testicular Cancer
Figure 10. ??
Figure 11. Cisplatin Injection Report Years Considered
Figure 12. Global Cisplatin Injection Sales 2017-2028 (K Units)
Figure 13. Global Cisplatin Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Cisplatin Injection Revenue 2017-2028 (US$ Million)
Figure 15. Global Cisplatin Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Cisplatin Injection Sales Market Share by Region (2017-2022)
Figure 17. Global Cisplatin Injection Sales Market Share by Region (2023-2028)
Figure 18. North America Cisplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 19. North America Cisplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Cisplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Cisplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Cisplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Cisplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Cisplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Cisplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Cisplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Cisplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Cisplatin Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Cisplatin Injection in the World: Market Share by Cisplatin Injection Revenue in 2021
Figure 30. Global Cisplatin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Cisplatin Injection Sales Market Share by Type (2017-2028)
Figure 32. Global Cisplatin Injection Revenue Market Share by Type (2017-2028)
Figure 33. Global Cisplatin Injection Sales Market Share by Application (2017-2028)
Figure 34. Global Cisplatin Injection Revenue Market Share by Application (2017-2028)
Figure 35. North America Cisplatin Injection Sales Market Share by Type (2017-2028)
Figure 36. North America Cisplatin Injection Revenue Market Share by Type (2017-2028)
Figure 37. North America Cisplatin Injection Sales Market Share by Application (2017-2028)
Figure 38. North America Cisplatin Injection Revenue
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs